Pitcairn Co. Decreases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Pitcairn Co. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 16,767 shares of the healthcare conglomerate’s stock after selling 2,093 shares during the period. UnitedHealth Group makes up approximately 0.6% of Pitcairn Co.’s holdings, making the stock its 24th largest holding. Pitcairn Co.’s holdings in UnitedHealth Group were worth $9,803,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Tealwood Asset Management Inc. purchased a new stake in UnitedHealth Group in the third quarter worth $2,905,000. Asset Planning Services Inc. LA ADV grew its position in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after buying an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in shares of UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after buying an additional 3,006 shares in the last quarter. Americana Partners LLC grew its position in shares of UnitedHealth Group by 10.8% during the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after buying an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. grew its position in shares of UnitedHealth Group by 14.8% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock worth $5,072,000 after buying an additional 1,283 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.1 %

Shares of NYSE:UNH opened at $590.77 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market cap of $543.67 billion, a price-to-earnings ratio of 38.49, a PEG ratio of 1.75 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a 50-day moving average price of $582.63 and a 200-day moving average price of $552.59.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period last year, the business earned $6.56 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent research reports. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. UBS Group dropped their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.